Jan Fikkan

Fikkan is currently CEO of Fikkan Pharma AS, performing consulting services as well as investments in Nordic early stage Healthcare and LifeScience companies. Jan has more than 30 years of experience in various executive roles in the international Pharma- and Medtech industry. He has a broad Business Development background and was running the Japan region for GE Healthcare for 13 years. This role included building infrastructure on the ground while optimization of the business through Strategic Alliances and JV structures. Fikkan has also been running the global R&D operations in GE Healthcare including responsibility for project/portfolio teams in UK, USA and Norway. Fikkan holds a Master of Science in Physiology from University of Oslo. He is currently deputy chairman of the board of Respinor AS and Respinor AB, and serves as business advisor for Investinor AS and Aleap AS. He is also a board member of Oxy Solutions AS. He joined the Board of SpinChip in 2015.